retatrutide side effects diarrhea The data just dropped — and is rewriting what's possible in obesity medicine. 🧬 TRIUMPH-1 just released Phase 3 results, and the numbers are unlike anything we've seen from a medication Unapproved weight loss drug retatrutide

Exhibit III Lexarias GLP-1 Agonist Human Studies Source: Lexaria Bioscience September 2025 Corporate Presentation Capital Raises September $4.0 Million Raise On September 26 th , Lexaria announced a $4.0 million registered direct offering priced at the market

Glutathione Creams: The Pros and Cons 1

The ICD-10-CM tabular list does not include a use additional code instruction at the E10 category because insulin dependence is assumed for all Type 1 patients

We will administer fluids to women in their 1st and 2nd trimester, with a note from their health care provider and approval from our medical director

A., & Lowe, J